| Source publication date | (updated; first published 2021-08-19) |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Testosterone and hormone clinic or telehealth website |
| Population | Women |
| Source | Winona |
| URL | bywinona.com/journal/trt-benefits-and-risks-for-women (opens in a new tab) |
Specific Claim Evaluated
Restoring testosterone to normal levels can help support bone density, may help reduce brain fog and supports clarity of thought, concentration and overall cognition in women.
Primary Research Supporting or Contradicting the Claim
The global consensus statement found insufficient data to support testosterone use in women for bone health or cognitive performance (Davis et al., 2019). A systematic review and meta-analysis of testosterone for cognition in menopause found the evidence insufficient to establish an effect (Faulkner et al., 2026).
Corrected Evidence-Based Interpretation
Testosterone has not been shown to improve bone density or cognition in women. Its only evidence-based use is for postmenopausal hypoactive sexual desire disorder.
Rationale for Grade
The page presents bone and cognitive benefits as outcomes of restoring testosterone and cites references by title only, without results. Consensus guidance and a 2026 meta-analysis find no supporting evidence for these indications.
References
- Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104(10):4660-4666. PMID
Supporting excerpt: "The only evidence-based indication for testosterone for women is for HSDD." - Faulkner A, Desai R, Keay N, Ellahi SA, Spector A. Testosterone therapy for cognition in menopause: a systematic review and meta-analysis. Reprod Fertil. 2026;7(4). PMID
Supporting excerpt: "insufficient to establish an effect rather than as evidence of no effect"